van Daalen K, Zhang D, Kaptoge S, Paige E, Di Angelantonio E, Pennells L
Lancet Glob Health. 2024; 12(8):e1343-e1358.
PMID: 39030064
PMC: 11283887.
DOI: 10.1016/S2214-109X(24)00210-9.
Whiteman D
Melanoma Manag. 2018; 1(2):105-114.
PMID: 30190816
PMC: 6094627.
DOI: 10.2217/mmt.14.15.
Ofori S, Odia O
Indian Heart J. 2016; 68(3):391-8.
PMID: 27316504
PMC: 4911434.
DOI: 10.1016/j.ihj.2015.07.004.
Kariuki J, Stuart-Shor E, Leveille S, Hayman L
BMC Cardiovasc Disord. 2013; 13:123.
PMID: 24373202
PMC: 3890583.
DOI: 10.1186/1471-2261-13-123.
Masic I, Rahimic M, Dilic M, Kadribasic R, Toromanovic S
Mater Sociomed. 2013; 23(3):171-83.
PMID: 23922510
PMC: 3732343.
DOI: 10.5455/msm.2011.23.171-183.
The Fremantle Primary Prevention Study: a multicentre randomised trial of absolute cardiovascular risk reduction.
Brett T, Arnold-Reed D, Phan C, Cadden F, Walker W, Manea-Walley W
Br J Gen Pract. 2012; 62(594):e22-8.
PMID: 22520669
PMC: 3252536.
DOI: 10.3399/bjgp12X616337.
Perceptions of risk: understanding cardiovascular disease.
Webster R, Heeley E
Risk Manag Healthc Policy. 2012; 3:49-60.
PMID: 22312218
PMC: 3270917.
DOI: 10.2147/RMHP.S8288.
Assessment of cardiovascular risk.
Cooney M, Cooney H, Dudina A, Graham I
Curr Hypertens Rep. 2010; 12(5):384-93.
PMID: 20838940
DOI: 10.1007/s11906-010-0143-1.
Implementation of a pharmacist-led clinic for hypertensive patients in primary care--a pilot study.
Reid F, Murray P, Storrie M
Pharm World Sci. 2005; 27(3):202-7.
PMID: 16096888
DOI: 10.1007/s11096-004-2563-y.
Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians.
Sheridan S, Pignone M, Mulrow C
J Gen Intern Med. 2003; 18(12):1039-52.
PMID: 14687264
PMC: 1494957.
DOI: 10.1111/j.1525-1497.2003.30107.x.
Comparative evaluation of the new Sheffield table and the modified joint British societies coronary risk prediction chart against a laboratory based risk score calculation.
Rabindranath K, Anderson N, Gama R, Holland M
Postgrad Med J. 2002; 78(919):269-72.
PMID: 12151567
PMC: 1742347.
DOI: 10.1136/pmj.78.919.269.
Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk.
Paterson J, Llewellyn-Thomas H, Naylor C
Health Expect. 2002; 5(1):3-15.
PMID: 11906538
PMC: 5060131.
DOI: 10.1046/j.1369-6513.2002.00148.x.
Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study.
McManus R, Mant J, Meulendijks C, Salter R, Pattison H, Roalfe A
BMJ. 2002; 324(7335):459-64.
PMID: 11859049
PMC: 65668.
DOI: 10.1136/bmj.324.7335.459.
Comparative accuracy of cardiovascular risk prediction methods in primary care patients.
Jones A, Walker J, Jewkes C, Game F, Bartlett W, Marshall T
Heart. 2000; 85(1):37-43.
PMID: 11119458
PMC: 1729574.
DOI: 10.1136/heart.85.1.37.
Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.
Kernick D
Br J Gen Pract. 2000; 50(458):697-8.
PMID: 11050783
PMC: 1313795.
The primary prevention of coronary heart disease with statins: practice headache or public health?.
Evans P
Br J Gen Pract. 2000; 50(458):695-7.
PMID: 11050782
PMC: 1313794.
Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.
Ritchie L
Br J Gen Pract. 2000; 50(458):693-5.
PMID: 11050781
PMC: 1313793.
Comparison of methods of estimating coronary risk. Authors did not use latest version of Sheffield table.
Wallis E, Ramsay L, Yikona J, Jackson P
BMJ. 2000; 321(7254):175-6.
PMID: 10950544
PMC: 1118172.
Risk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs.
Neary R, Ramachandran S
BMJ. 2000; 321(7254):174.
PMID: 10950539
PMC: 1118171.
Guidelines on preventing cardiovascular disease in clinical practice.
Jackson R
BMJ. 2000; 320(7236):659-61.
PMID: 10710556
PMC: 1117692.
DOI: 10.1136/bmj.320.7236.659.
